HCPCS M0234
Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
INTRAVENOUS INFUSION, TOCILIZUMAB-AAZG, FOR HOSPITALIZED ADULT PATIENTS WITH COVID-19 WHO ARE RECEIVING SYSTEMIC CORTICOSTEROIDS AND REQUIRE SUPPLEMENTAL OXYGEN, NON-INVASIVE OR INVASIVE MECHANICAL VENTILATION, OR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) ONLY, INCLUDES INFUSION AND POST ADMINISTRATION MONITORING, SECOND DOSE
Prices here combine facility and professional fees. See them separately →Experimental
Low
$938
Average
$938
Median
$938
High
$938
Filter by billing methodology
Reflects a payer-specific billing methodology not covered by the standard categories.
| # | Hospital | ||||||
|---|---|---|---|---|---|---|---|
| 1 | Bellevue Medical Center Llc Bellevue, NE | $775 | $938 | $402 | 43% | — | $775 – $2.0k |
| 2 | Nebraska Medical Center Omaha, NE | $775 | $938 | $402 | 43% | — | $775 – $2.0k |
Ask Claude or any MCP client for HCPCS M0234 pricing at a specific hospital — see how to connect.